Ignite Creation Date:
2024-05-05 @ 5:20 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00436826
Status:
COMPLETED
Last Update Posted:
2020-10-12
First Post:
2007-02-15
Brief Title:
A Phase 2 Study of Cladribine Add-on to Interferon-beta IFN-beta Therapy in Multiple Sclerosis MS Subjects With Active Disease ONWARD
Sponsor:
EMD Serono Research Development Institute Inc
Organization:
EMD Serono
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-11-30
Start Date Type:
ACTUAL
Primary Completion Date:
2011-09-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-03-31
Completion Date Type:
ACTUAL
First Submit Date:
2007-02-15
First Submit QC Date:
February 16 2007
Study First Post Date:
2007-02-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2013-07-01
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-10-08
Last Update Post Date:
2020-10-12
Last Update Post Date Type:
ACTUAL